An increasing number of companies traded on the Tel Aviv Stock Exchange are considering listings in the US, with emphasis on NASDAQ, through American Depositary Receipts (ADRs). This trend is particularly noticeable among Israeli companies engaged in the life sciences field.
ADRs provide Israeli companies with access to the US capital markets at a lower cost than traditional IPOs, making it possible to gradually build a market and attract investors to follow the performance of the companies. Such exposure can lead up to equity financing on the US capital markets, and ADRs can also be used as currency in international M&A transactions.
The Corporate and Capital Markets Department specializes in preparing companies for ADR trading, including drafting and filing prospectus and dealings with the U.S. Securities and Exchange Commission (SEC), and advising public companies, directors and offices, on all aspects of disclosure and reporting obligations and compliance with the SEC Rules.
.jpg "The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic")
.jpg "Attorneys Oded Har-Even, David Huberman and Robert Condon represented Nano Dimension Ltd.")
.jpg "IATI’s forum of public biomed companies")
.jpg "The firm represented the US investment bank Gunner & Joseph in a public offering of Rennova Health.")
.jpg "The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of approximately $1 million")
.jpg "ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million")
.jpg "Our firm represented EasyPark, a Swedish company, in it's acquisition of the Israeli company, Parko")
.jpg "ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million")
.jpg "Attorneys Mor Limanovich and Marie Orlovsky represented Zeekit Ltd. in a finanacing round of $9 million")
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics")
.jpg "Insuline Medical Ltd. raised additional NIS2.2 million")
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.")
.jpg "ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.")
.jpg "Another successful financing round of $25 million for SimilarWeb")
.jpg "ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment")
.jpg "Adv. Mor Limanovich represented NSLComm in a financing round of $2.5 million from JVP and additional investors")
